{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:55:58Z","timestamp":1789232158942,"version":"build-2803163510"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    In Japan, the involvement of hospital pharmacists in inappropriate medications (IMs) practices has not been sufficiently reported. Therefore, this prospective study described the interventions of hospital pharmacists in discontinuing inappropriate drugs or reducing drug doses.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    We conducted a prospective, multicenter, observational study to investigate the intervention of hospital pharmacists in inappropriate prescriptions for inpatients in September 2018. Fifty pharmacists from 45 hospitals in Japan participated in this study. IMs were defined as medications that pharmacists deemed inappropriate for patient treatment. The subjects of the study were patients who interacted with the participating pharmacists.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    During the study period, the median number of beds in hospitals where the 50 participating pharmacists worked was 380, and the average number of beds for which the pharmacists were responsible was 49. The enrolled hospital pharmacists recommended that doctors discontinue or reduce the doses of their regular drugs for 347 out of 1,415 (24.5%) patients. Among the 391 pharmacists\u2019 recommendations to reduce IMs for 347 patients, physicians accepted 368 (94.1%) recommendations, and 523 drugs were discontinued as a result. Pharmacist intervention also led to improvements in hypnotic sedation, delirium, and hypotension. The most common reasons for IMs identified by pharmacists were \u201clong-term administration of irresponsible or aimless medications\u201d (44.5%), \u201cadverse effects caused by medications\u201d (31.5%), and \u201cmedications-mediated duplication of the pharmacological effect\u201d (15.3%). Approximately 90% of pharmacists\u2019 suggestions to reduce medications were accepted for each reason. The average number of regular medications used by patients involved in drug reduction was 8.2, and the average number of medications reduced was 1.7. A sub-analysis showed that patients using opioids tended to take more medications, and these patients were able to reduce the amount of medications taken. Interventions by pharmacists certified in palliative pharmacies tended to reduce adverse drug events.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    This was the first multicenter prospective observational study conducted in Japan to demonstrate hospital pharmacist intervention\u2019s effectiveness in promoting appropriate prescription and, consequently, a reduction in the number of medications in use and polypharmacy.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2023.1195732","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:59:46Z","timestamp":1688086786000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Multicenter prospective observational study on hospital pharmacist interventions to reduce inappropriate medications"],"prefix":"10.3389","volume":"14","author":[{"given":"Shinya","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayako","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Suga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisamitsu","family":"Takase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.2165\/11538310-000000000-00000","article-title":"Pharmacists' interventions in prescribing errors at hospital discharge: An observational study in the context of an electronic prescribing system in a UK teaching hospital","volume":"33","author":"Abdel-Qader","year":"2010","journal-title":"Drug Saf."},{"key":"B2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1177\/0018578720985428","article-title":"Impact of clinical pharmacist interventions in prescribing errors in hospitalized diabetic patients with major polypharmacy","volume":"56","author":"Abu-Naser","year":"2021","journal-title":"Hosp. Pharm."},{"key":"B4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/jama.274.1.29","article-title":"Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group","volume":"274","author":"Bates","year":"1995","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1592\/phco.26.5.601","article-title":"Adverse drug reactions in United States hospitals","volume":"26","author":"Bond","year":"2006","journal-title":"Pharmacotherapy"},{"key":"B6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1592\/phco.27.4.481","article-title":"Clinical pharmacy services, pharmacy staffing, and hospital mortality rates","volume":"27","author":"Bond","year":"2007","journal-title":"Pharmacotherapy"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","article-title":"Emergency hospitalizations for adverse drug events in older Americans","volume":"365","author":"Budnitz","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B3","first-page":"456","article-title":"Patients and polypharmacy","volume":"94","year":"1966","journal-title":"Can. Med. Assoc. J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/jamainternmed.2017.0911","article-title":"Polypharmacy in the elderly-when good drugs lead to bad outcomes: A teachable moment","volume":"177","author":"Carroll","year":"2017","journal-title":"JAMA Intern Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1445-5994.2001.00044.x","article-title":"Adverse drug events as a cause of hospital admission in the elderly","volume":"31","author":"Chan","year":"2001","journal-title":"Intern Med. J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/JXX.0000000000000082","article-title":"2015 Beers criteria medication review in assisted living facilities","volume":"30","author":"Chun","year":"2018","journal-title":"J. Am. Assoc. Nurse Pract."},{"key":"B11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1041-2972.2005.0020.x","article-title":"Polypharmacy in the elderly: A literature review","volume":"17","author":"Fulton","year":"2005","journal-title":"J. Am. Acad. Nurse Pract."},{"key":"B12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jamda.2020.09.039","article-title":"A new care model reduces polypharmacy and potentially inappropriate medications in long-term care","volume":"22","author":"Garland","year":"2021","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.vascn.2016.04.011","article-title":"Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital","volume":"81","author":"Geer","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"B14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.amjopharm.2007.12.002","article-title":"Polypharmacy in elderly patients","volume":"5","author":"Hajjar","year":"2007","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/archinternmed.2011.215","article-title":"Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients","volume":"171","author":"Hamilton","year":"2011","journal-title":"Arch. Intern Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s40266-013-0118-4","article-title":"The medication appropriateness index at 20: Where it started, where it has been, and where it may be going","volume":"30","author":"Hanlon","year":"2013","journal-title":"Drugs Aging"},{"key":"B17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12913-016-1408-4","article-title":"Effect of pharmacist intervention on physician prescribing in patients with chronic schizophrenia: A descriptive pre\/post study","volume":"16","author":"Hashimoto","year":"2016","journal-title":"BMC Health Serv. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11912-017-0632-3","article-title":"Polypharmacy in the geriatric oncology population","volume":"19","author":"Hersh","year":"2017","journal-title":"Curr. Oncol. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13104-020-05032-2","article-title":"Effects of pharmacist intervention on polypharmacy in patients with type 2 diabetes in Japan","volume":"13","author":"Horii","year":"2020","journal-title":"BMC Res. Notes"},{"key":"B20","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2165\/00002018-200730100-00009","article-title":"The relationship between number of drugs and potential drug-drug interactions in the elderly: A study of over 600,000 elderly patients from the Swedish prescribed drug register","volume":"30","author":"Johnell","year":"2007","journal-title":"Drug Saf."},{"key":"B21","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.japh.2017.06.002","article-title":"Association between polypharmacy and death: A systematic review and meta-analysis","volume":"57","author":"Leelakanok","year":"2017","journal-title":"J. Am. Pharm. Assoc. JAPhA."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1001\/archinternmed.2008.3","article-title":"Frequency of and risk factors for preventable medication-related hospital admissions in The Netherlands","volume":"168","author":"Leendertse","year":"2008","journal-title":"Arch. Intern Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cger.2017.01.007","article-title":"Polypharmacy reduction strategies: Tips on incorporating American Geriatrics society beers and screening Tool of older people's prescriptions criteria","volume":"33","author":"Levy","year":"2017","journal-title":"Clin. Geriatr. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.nurpra.2013.09.010","article-title":"Deprescribing: An approach to reducing polypharmacy in nursing home residents","volume":"10","author":"Liu","year":"2014","journal-title":"J. Nurse Pract."},{"key":"B25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","article-title":"Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications","volume":"57","author":"Mangoni","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s11606-010-1518-3","article-title":"Incidence of adverse drug events and medication errors in Japan: The JADE study","volume":"26","author":"Morimoto","year":"2011","journal-title":"J. Gen. Intern Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1093\/ajhp\/59.22.2221","article-title":"Effectiveness of a pharmacist-acquired medication history in promoting patient safety","volume":"59","author":"Nester","year":"2002","journal-title":"Am. J. Health Syst. Pharm."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s40264-016-0458-1","article-title":"Prevention of medication errors in hospitalized patients: The Japan adverse drug events study","volume":"39","author":"Noguchi","year":"2016","journal-title":"Drug Saf."},{"key":"B30","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/ijpp.12541","article-title":"Factors associated with potentially inappropriate medication use in community-dwelling older adults in the United States: A systematic review","volume":"27","author":"Nothelle","year":"2019","journal-title":"Int. J. Pharm. Pract."},{"key":"B31","doi-asserted-by":"publisher","first-page":"806 e1","DOI":"10.1016\/j.jamda.2017.06.005","article-title":"Determinants of potentially inappropriate medication use in long-term and acute care settings: A systematic review","volume":"18","author":"Nothelle","year":"2017","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"B32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2165\/11632610-000000000-00000","article-title":"Inappropriate prescribing: Criteria, detection and prevention","volume":"29","author":"O'Connor","year":"2012","journal-title":"Drugs Aging"},{"key":"B33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: Version 2","volume":"44","author":"O'Mahony","year":"2015","journal-title":"Age Ageing"},{"key":"B34","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1248\/yakushi.18-00181-5","article-title":"Appropriate use of medicine and polypharmacy in older patients","volume":"139","author":"Ooi","year":"2019","journal-title":"Yakugaku Zasshi"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults","volume":"63","author":"Panel","year":"2015","journal-title":"J. Am. Geriatr. Soc."},{"key":"B36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.5414\/CP202484","article-title":"Prescribed drugs and polypharmacy in healthcare service users in South Korea: An analysis based on national health insurance claims data","volume":"54","author":"Park","year":"2016","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40266-014-0163-7","article-title":"Medication non-adherence among elderly patients newly discharged and receiving polypharmacy","volume":"31","author":"Pasina","year":"2014","journal-title":"Drugs Aging"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","article-title":"A systematic review of the emerging defiition of \u2018deprescribing\u2019 with network analysis: Implications for future research and clinical practice","volume":"80","author":"Reeve","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/bcp.12386","article-title":"Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process","volume":"78","author":"Reeve","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s11606-019-04837-7","article-title":"Associations between polypharmacy, symptom burden, and quality of life in patients with advanced, life-limiting illness","volume":"34","author":"Schenker","year":"2019","journal-title":"J. Gen. Intern Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/clinpract13020040","article-title":"Teaching deprescribing and combating polypharmacy in the pharmacy curriculum: Educational recommendations from thematic analysis of focus groups","volume":"13","author":"Scott","year":"2023","journal-title":"Clin. Pract."},{"key":"B42","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: The process of deprescribing","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1248\/bpb.b19-00043","article-title":"A nationwide survey of community pharmacist contributions to polypharmacy in opioid-using and non-using cancer patients in Japan","volume":"42","author":"Suzuki","year":"2019","journal-title":"Biol. Pharm. Bull."},{"key":"B44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40780-019-0143-5","article-title":"A nationwide survey of hospital pharmacist interventions to improve polypharmacy for patients with cancer in palliative care in Japan","volume":"5","author":"Uchida","year":"2019","journal-title":"J. Pharm. Health Care Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/ijpp\/riac032","article-title":"Multicentre prospective observational study on community pharmacist interventions to reduce inappropriate medications","volume":"30","author":"Uchida","year":"2022","journal-title":"Int. J. Pharm. Pract."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00228-015-1908-x","article-title":"Majority of drug-related problems identified during medication review are not associated with STOPP\/START criteria","volume":"71","author":"Verdoorn","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1080\/14740338.2018.1546841","article-title":"An update on the clinical consequences of polypharmacy in older adults: A narrative review","volume":"17","author":"Wastesson","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"B48","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jppr2003334323","article-title":"Deprescribing: Achieving better health outcomes for older people through reducing medications","volume":"33","author":"Woodward","year":"2003","journal-title":"J. Pharm. Pract. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1503\/cmaj.071594","article-title":"Incidence, severity and preventability of medication-related visits to the emergency department: A prospective study","volume":"178","author":"Zed","year":"2008","journal-title":"CMAJ"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1195732\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:59:49Z","timestamp":1688086789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1195732\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":49,"alternative-id":["10.3389\/fphar.2023.1195732"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1195732","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"article-number":"1195732"}}